Theratechnologies Inc (THTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 08-2016 | 05-2016 | 02-2016 | 11-2015 | 08-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 183 | -501 | -110 | 1,248 | 840 |
| Depreciation Amortization | 1,172 | 789 | 380 | 1,523 | 1,100 |
| Accounts receivable | -1,919 | -2,160 | -904 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,195 | 433 | -254 | N/A | N/A |
| Other Working Capital | -2,818 | -1,418 | -481 | 895 | -400 |
| Other Operating Activity | 4,580 | 3,334 | 1,649 | 1,965 | 1,470 |
| Operating Cash Flow | $2 | $478 | $280 | $5,631 | $3,010 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,836 | -3,430 | -3,210 | N/A | N/A |
| PPE Investments | -24 | -15 | -4 | 54 | 50 |
| Purchase Sale Intangibles | -59 | -1,147 | N/A | N/A | N/A |
| Other Investing Activity | -1,209 | -1,147 | 0 | 1,960 | 1,930 |
| Investing Cash Flow | $-8,069 | $-4,592 | $-3,214 | $2,014 | $1,980 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,005 | -3,997 | N/A | N/A | N/A |
| Common Stock Issued | 170 | 169 | N/A | N/A | N/A |
| Other Financing Activity | -19 | -19 | -18 | 3,596 | 6,020 |
| Financing Cash Flow | $-3,854 | $-3,847 | $-18 | $3,596 | $6,020 |
| Exchange Rate Effect | 336 | -209 | 48 | 406 | 310 |
| Beginning Cash Position | 11,830 | 11,807 | 11,049 | 552 | 540 |
| End Cash Position | 247 | 3,638 | 8,145 | 12,199 | 11,890 |
| Net Cash Flow | $-11,584 | $-8,169 | $-2,904 | $11,647 | $11,340 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2 | 478 | 280 | 5,631 | 3,010 |
| Capital Expenditure | -24 | -15 | -4 | N/A | N/A |
| Free Cash Flow | -22 | 463 | 276 | 5,631 | 3,010 |